B-cell prolymphocytic leukemia: Difference between revisions
Carlos Lopez (talk | contribs) |
No edit summary |
||
Line 2: | Line 2: | ||
{{B-cell prolymphocytic leukemia}} | {{B-cell prolymphocytic leukemia}} | ||
{{SI}} | {{SI}} | ||
{{CMG}} {{CLG}} | {{CMG}}; {{AE}}{{Qurrat}}, {{CLG}} | ||
{{SK}} B-PLL, Prolymphocytic leukemia, B-cell type | {{SK}} B-PLL, Prolymphocytic leukemia, B-cell type |
Latest revision as of 16:33, 1 April 2019
B-cell prolymphocytic leukemia |
Differentiating B-cell prolymphocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
B-cell prolymphocytic leukemia On the Web |
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia |
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
Risk calculators and risk factors for B-cell prolymphocytic leukemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Carlos A Lopez, M.D. [3]
Synonyms and keywords: B-PLL, Prolymphocytic leukemia, B-cell type
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating B-cell prolymphocytic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Biopsy | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies